My Portfolio
+
LINK YOUR PORTFOLIO

Abcellera Biologics Inc ABCL:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 06/02/26 EDT
5.72quote price arrow down-0.41 (-6.69%)
Volume
5,190,921
52 week range
2.09 - 6.79
Loading...
  • Open6.01
  • Day High6.01
  • Day Low5.61
  • Prev Close5.72
  • 52 Week High6.79
  • 52 Week High Date06/01/26
  • 52 Week Low2.09
  • 52 Week Low Date06/03/25

Latest On Abcellera Biologics Inc

 

Key Stats

  • Market Cap1.747B
  • Shares Out305.38M
  • 10 Day Average Volume8.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.19

Latest On Abcellera Biologics Inc

 

KEY STATS

  • Open6.01
  • Day High6.01
  • Day Low5.61
  • Prev Close5.72
  • 52 Week High6.79
  • 52 Week High Date06/01/26
  • 52 Week Low2.09
  • 52 Week Low Date06/03/25
  • Market Cap1.747B
  • Shares Out305.38M
  • 10 Day Average Volume8.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.19

RATIOS/PROFITABILITY

  • EPS (TTM)-0.48
  • P/E (TTM)-11.92
  • Fwd P/E (NTM)-8.29
  • EBITDA (TTM)-188.286M
  • ROE (TTM)-14.68%
  • Revenue (TTM)79.207M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-181.75%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/05/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two...
Carl Hansen Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Andrew Booth
Chief Financial Officer
Address
150 W 4Th Avenue
Vancouver, BC
V6E 4E5
Canada